Evaluation of the efficacy and safety of lixisenatide add-on treatment to basal insulin therapy among T2DM patients with different body mass indices from GetGoal trials
Crossref DOI link: https://doi.org/10.1186/s13098-015-0104-6
Published Online: 2015-11-21
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Eto, Kazuhiro
Naito, Yusuke
Seino, Yutaka
Funding for this research was provided by:
Sanofi K.K.
